- Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial. Eron, J.J., Feinberg, J., Kessler, H.A., Horowitz, H.W., Witt, M.D., Carpio, F.F., Wheeler, D.A., Ruane, P., Mildvan, D., Yangco, B.G., Bertz, R., Bernstein, B., King, M.S., Sun, E. J. Infect. Dis. (2004)